TBPH icon

Theravance Biopharma

108 hedge funds and large institutions have $1.16B invested in Theravance Biopharma in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 28 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

17% more funds holding

Funds holding: 92108 (+16)

2.59% less ownership

Funds ownership: 81.55%78.97% (-2.6%)

45% less call options, than puts

Call options by funds: $726K | Put options by funds: $1.33M

Holders
108
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$726K
Puts
$1.33M
Net Calls
Net Calls Change

Top Buyers

1 +$82.3M
2 +$9.1M
3 +$4.49M
4
Norges Bank
Norges Bank
Norway
+$3.11M
5
NM
Newtyn Management
New York
+$2.84M

Top Sellers

1 -$5.09M
2 -$2.52M
3 -$1.79M
4
Squarepoint
Squarepoint
New York
-$967K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$722K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$241M
2
$219M
3
$135M
4
$104M
5
$99.1M
6
$82.3M
7
$27.8M
8
$24.8M
9
$24.6M
10
$17M
11
$15.8M
12
$15.7M
13
$14.8M
14
$13.6M
15
$11.7M
16
$9.08M
17
$7.19M
18
$7.04M
19
$6.94M
20
$6.07M
21
$5.26M
22
$5.09M
23
$4.49M
24
$4.49M
25
$3.84M